NOVELIX PHARMACEUTICALS
Sector : Pharmaceuticals and health care | Smallcap | BSE
Here's the live share price of Novelix Pharmaceuticals along with daily highs, lows, percentage changes and volume trends, and, all financial information.
-1.07₹ -0.56
As on Nov 4, 2025, 4:01 PM IST
Novelix Pharmaceuticals Price Performance
Today's LowToday's High
₹52.00₹54.00
₹52.00
52 Weeks' Low52 Weeks' High
₹21.91₹57.65
₹52.00
Open Price
₹52.55
Prev. Close
₹52.56
Volume
16,940
Over the last 5 years, the share price of Novelix Pharmaceuticals has gained 49.43% CAGR. Over the past year, the corresponding return has been 137.33%.
Novelix Pharmaceuticals’s current P/E of -18.23x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Breakout Stocks Screener.
Novelix Pharmaceuticals Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Novelix Pharmaceuticals | -0.57 | 29.35 | 30.00 | 95.42 | 137.33 | 73.42 | 49.43 |
| Sun Pharmaceutical Industries | 0.33 | 2.35 | 3.15 | -7.76 | -6.42 | 17.65 | 27.40 |
| Divi's Laboratories | 6.12 | 17.18 | 5.13 | 11.31 | 15.80 | 22.16 | 16.40 |
| Cipla | -4.08 | -0.53 | -0.64 | -2.42 | -4.97 | 9.52 | 14.02 |
| Torrent Pharmaceuticals | -0.10 | 1.39 | -1.07 | 8.86 | 11.75 | 28.91 | 22.42 |
| Dr. Reddy's Laboratories | -6.95 | -3.82 | -2.01 | 2.41 | -5.30 | 9.89 | 4.00 |
| Zydus Lifesciences | -2.85 | -2.16 | 1.37 | 9.05 | -3.13 | 30.30 | 17.26 |
| Mankind Pharma | -1.47 | -3.37 | -9.86 | -1.93 | -13.37 | 18.50 | 10.72 |
| Lupin | 4.01 | 3.10 | 6.12 | -4.27 | -8.71 | 41.14 | 16.17 |
| Alkem Laboratories | 4.30 | 3.20 | 15.47 | 11.61 | -2.26 | 20.29 | 16.02 |
| Aurobindo Pharma | 4.77 | 5.10 | 5.60 | -7.30 | -18.14 | 27.67 | 8.06 |
| Abbott India | -1.34 | -2.12 | -13.63 | -4.47 | -0.20 | 14.70 | 13.16 |
| Laurus Labs | 2.36 | 13.77 | 14.00 | 58.86 | 101.49 | 28.34 | 28.79 |
| Glenmark Pharmaceuticals | 1.69 | -6.33 | -10.97 | 31.35 | 8.61 | 63.66 | 29.98 |
| Biocon | 3.92 | 9.50 | -0.58 | 13.22 | 22.27 | 11.53 | -1.52 |
| GlaxoSmithKline Pharmaceuticals | 0.21 | -2.66 | -7.06 | -7.98 | 1.93 | 25.53 | 13.79 |
| Anthem Biosciences | -1.49 | -8.06 | -6.71 | -3.81 | -3.81 | -1.29 | -0.77 |
| Ipca Laboratories | 0.77 | -2.12 | -10.29 | -6.88 | -18.52 | 12.62 | 1.79 |
| Ajanta Pharma | 8.79 | 6.76 | -1.59 | 0.20 | -13.37 | 27.38 | 19.28 |
| Gland Pharma | 0.17 | -1.74 | -3.80 | 34.33 | 18.38 | 1.73 | 0.92 |
Over the last one year, Novelix Pharmaceuticals has gained 137.33% compared to peers like Sun Pharmaceutical Industries (-6.42%), Divi's Laboratories (15.80%), Cipla (-4.97%). From a 5 year perspective, Novelix Pharmaceuticals has outperformed peers relative to Sun Pharmaceutical Industries (27.40%) and Divi's Laboratories (16.40%).
Novelix Pharmaceuticals Financials
Novelix Pharmaceuticals Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 52.73 | 52.32 |
| 10 | 49.39 | 50.28 |
| 20 | 44.9 | 47.28 |
| 50 | 42.37 | 43.66 |
| 100 | 40.79 | 39.42 |
| 200 | 28.86 | 32.09 |
Novelix Pharmaceuticals Share Holding Pattern
In the latest quarter, Novelix Pharmaceuticals saw a rise in promoter holding to 54.81%, while DII stake unchanged at 0.00%, FII holding unchanged at 0.00%, and public shareholding moved down to 45.19% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Novelix Pharmaceuticals Corporate Actions
Date Time | Announcement |
|---|---|
| Oct 24, 2025, 2:41 AM IST | Novelix Pharmaceutic - Announcement under Regulation 30 (LODR)-Allotment |
| Oct 24, 2025, 2:38 AM IST | Novelix Pharmaceutic - Announcement under Regulation 30 (LODR)-Change in Directorate |
| Oct 18, 2025, 2:02 AM IST | Novelix Pharmaceutic - Intimation Regarding The Execution Of An Agreement With GMBU E.V., Halle (Saale), Germany. |
| Oct 17, 2025, 1:35 AM IST | Novelix Pharmaceutic - Announcement under Regulation 30 (LODR)-Press Release / Media Release |
| Sep 21, 2025, 4:59 PM IST | Novelix Pharmaceutic - Shareholders Meeting- AGM |
About Novelix Pharmaceuticals
Novelix Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 21/10/1993 and has its registered office in the State of Telangana, India. Company's Corporate Identification Number(CIN) is L67120TG1994PLC018956 and registration number is 018956. Currently Company is involved in the business activities of Manufacture of macaroni, noodles, couscous and similar farinaceous products. Company's Total Operating Revenue is Rs. 30.72 Cr. and Equity Capital is Rs. 9.95 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- AddressAmrutha Estates, 6th floor, H.No. 3-6-237/610, Hyderabad Telangana 500029
- Contact
Management
- Mrs. Monam KapoorInd. Non-Executive Director
- Mr. Venkateshwarlu PulluruWhole Time Director
- Mr. Janardhan Das KabraInd. Non-Executive Director
- Mr. Gattu Gnana PrakashInd. Non-Executive Director
- Mr. Jivamohan Divakar ValluriNon Exe.Non Ind.Director
- Mr. Lakshman SamalaInd. Non-Executive Director
- Ms. Mayuri BaidyaInd. Non-Executive Director
FAQs on Novelix Pharmaceuticals Share Price
What is the share price of Novelix Pharmaceuticals?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Novelix Pharmaceuticals is ₹52.00 as on Nov 04, 2025.
What kind of stock is Novelix Pharmaceuticals?
The Novelix Pharmaceuticals is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of Novelix Pharmaceuticals?
The market cap of Novelix Pharmaceuticals is ₹42.12 Cr as on Nov 04, 2025.
What are today's High and Low prices of Novelix Pharmaceuticals?
Today’s highest and lowest price of Novelix Pharmaceuticals are ₹54.00 and ₹52.00.
What are the 52 Week High and 52 Week Low of Novelix Pharmaceuticals?
The 52-week high/low is the highest and lowest price at which Novelix Pharmaceuticals stock has traded in the past 52-week or nearly a year. The 52-week high of Novelix Pharmaceuticals is ₹57.65 and 52-week low of Novelix Pharmaceuticals is ₹21.91 as on Nov 04, 2025.
How has the Novelix Pharmaceuticals performed historically in terms of returns?
The Novelix Pharmaceuticals has shown returns of -1.07% over the past day, 29.35% for the past month, 30.0% over 3 months, 137.33% over 1 year, 73.42% across 3 years, and 49.43% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Novelix Pharmaceuticals?
P/E ratio of and PB ratio of Novelix Pharmaceuticals are -18.23 and 5.69 on Nov 04, 2025. While the company gives a dividend yield of 0.00 per annum.
✕
Market Pulse